BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2194506)

  • 21. Recombinant GM-CSF in myelosuppression of chemotherapy.
    N Engl J Med; 1989 Jan; 320(4):253-4. PubMed ID: 2643049
    [No Abstract]   [Full Text] [Related]  

  • 22. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.
    Gianni AM; Bregni M; Siena S; Orazi A; Stern AC; Gandola L; Bonadonna G
    J Clin Oncol; 1990 May; 8(5):768-78. PubMed ID: 2185337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytokines in clinical use].
    Meyer P; Wilms K
    Internist (Berl); 1988 Nov; 29(11):717-26. PubMed ID: 2466805
    [No Abstract]   [Full Text] [Related]  

  • 24. Hematopoietic growth factors: biology and clinical application.
    Gabrilove JL; Jakubowski A
    J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic uses of macrophage colony-stimulating factor.
    Nadler PI
    Cancer Invest; 1990; 8(2):299-300. PubMed ID: 2205341
    [No Abstract]   [Full Text] [Related]  

  • 26. [Stem cell-colony stimulating factors].
    Urabe A; Kobayashi Y; Takaku F
    Gan No Rinsho; 1989 May; Spec No():287-93. PubMed ID: 2481048
    [No Abstract]   [Full Text] [Related]  

  • 27. Granulocyte-macrophage colony-stimulating factor (GM-CSF), hypocalcemia, and hypomagnesemia.
    Potter MN; Mott MG; Oakhill A
    Ann Intern Med; 1990 May; 112(9):715. PubMed ID: 2185678
    [No Abstract]   [Full Text] [Related]  

  • 28. Colony stimulating factors: twenty years from discovery to clinical trials.
    Morstyn G; Fox R
    Aust N Z J Surg; 1988 Apr; 58(4):275-7. PubMed ID: 2473735
    [No Abstract]   [Full Text] [Related]  

  • 29. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
    Rifkin RM; Hersh EM; Salmon SE
    Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GM-CSF in combination with cytotoxic chemotherapy in AML patients.
    Bettelheim P; Muhm M; Valent P; Geissler K; Andreeff M; Haimi J; Sillaber C; Hinterberger W; Vieder L; Schulz G
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():127-30. PubMed ID: 2202464
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
    Champlin RE; Nimer SD; Oette D; Golde DW
    Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
    [No Abstract]   [Full Text] [Related]  

  • 32. Theoretical and practical issues concerning the use of rhGM-CSF and rhIL-3: present status.
    Jones TC
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():36-7. PubMed ID: 2180518
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group.
    Gerhartz HH; Visani G; Delmer A; Zwierzina H; Ribeiro M; Jacobs A; Marcus R; Baumelou M; Fière D; Labar B
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():36-7. PubMed ID: 2697397
    [No Abstract]   [Full Text] [Related]  

  • 34. Methimazole-induced agranulocytosis and granulocyte-colony stimulating factor.
    Heinrich B; Gross M; Goebel FD
    Ann Intern Med; 1989 Oct; 111(7):621-2. PubMed ID: 2672934
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
    Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
    N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of a marrow stem-cell disorder with granulocyte colony-stimulating factor.
    Quesenberry PJ
    N Engl J Med; 1989 May; 320(20):1343-5. PubMed ID: 2469957
    [No Abstract]   [Full Text] [Related]  

  • 37. The promise of colony-stimulating factors in clinical practice.
    Glaspy JA; Ambersley JM
    Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candidal endocarditis and treatment with fluconazole and granulocyte-macrophage colony-stimulating factor.
    Martino P; Meloni G; Cassone A
    Ann Intern Med; 1990 Jun; 112(12):966-7. PubMed ID: 2187396
    [No Abstract]   [Full Text] [Related]  

  • 39. [Expectations in the clinical application of human-recombinant cytokines. 4) Interleukin-3 and colony-stimulation factors].
    Takaku F
    Nihon Rinsho; 1988 May; 46(5):1105-11. PubMed ID: 2457722
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of colony stimulating factors on cancer chemotherapy.
    Morstyn G
    Br J Haematol; 1990 Jul; 75(3):303-7. PubMed ID: 1696832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.